LRIG1, the best-studied LRIG family member, negatively regulates the signaling pathways mediated by ERBB [5], [6], MET [7] and RET [8] receptor tyrosine kinases, and is suggested to be a tumor suppressor [9]. This evidence concerns the gene EGFR and neoplasm.